Table 4.
Domain | Use (low risk) | Abuse (moderate risk) | Dependence (high risk) | F-value, p-value | G-H |
---|---|---|---|---|---|
|
Mean (SD), n |
Mean (SD), n |
Mean (SD), n |
|
|
3A: SSI score for tobacco |
naa |
na |
na |
na |
na |
3B: SSI score for alcohol |
2.9 (3.2), 89 |
na |
22.7 (9.6), 4 |
-3.5, p < 0.0005b |
na |
3C: SSI score for cannabis |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3D: SSI score for cocaine |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3E: SSI score for ATS |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3F: SSI score for Inhalants |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3G: SSI score for sedatives |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3H: SSI score for hallucinogens |
0 (0), 100 |
na, 0 |
na, 0 |
na |
na |
3I: SSI score for opioids | 0 (0), 100 | na, 0 | na, 0 | na | na |
ainformation not available from questionnaire or unable to perform post hoc test because there are fewer than 3 groups.
bcomparison by Mann–Whitney test because only 2 non-empty groups and too small sample size.